161 related articles for article (PubMed ID: 33939384)
41. Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study.
Imperiale TF; Monahan PO; Stump TE; Glowinski EA; Ransohoff DF
Ann Intern Med; 2015 Sep; 163(5):339-46. PubMed ID: 26259154
[TBL] [Abstract][Full Text] [Related]
42. Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?
van Turenhout ST; Oort FA; van der Hulst RW; Visscher AP; Terhaar sive Droste JS; Scholten P; Bouman AA; Meijer GA; Mulder CJ; van Rossum LG; Coupé VM
BMC Gastroenterol; 2014 Dec; 14():217. PubMed ID: 25528043
[TBL] [Abstract][Full Text] [Related]
43. Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis.
Selby K; Levine EH; Doan C; Gies A; Brenner H; Quesenberry C; Lee JK; Corley DA
Gastroenterology; 2019 Dec; 157(6):1494-1505. PubMed ID: 31472152
[TBL] [Abstract][Full Text] [Related]
44. Head-to-head comparison of a risk-adapted screening strategy using various risk prediction models in detecting colorectal neoplasm.
Lu M; Zhang Y; Cai J; Lu B; Luo C; Chen H; Dai M
J Gastroenterol Hepatol; 2022 Jul; 37(7):1244-1252. PubMed ID: 35263809
[TBL] [Abstract][Full Text] [Related]
45. Combined Performance of Fecal Immunochemical Tests and a Genetic Risk Score for Advanced Neoplasia Detection.
Niedermaier T; Guo F; Weigl K; Hoffmeister M; Brenner H
Cancer Prev Res (Phila); 2022 Aug; 15(8):543-552. PubMed ID: 35679356
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of screening using annual fecal immunochemical test alone versus combined with one-time colonoscopy in reducing colorectal cancer mortality: the Akita Japan population-based colonoscopy screening trial (Akita pop-colon trial).
Saito H; Kudo SE; Takahashi N; Yamamoto S; Kodama K; Nagata K; Mizota Y; Ishida F; Ohashi Y
Int J Colorectal Dis; 2020 May; 35(5):933-939. PubMed ID: 32034490
[TBL] [Abstract][Full Text] [Related]
47. Fecal hemoglobin concentration is useful for risk stratification of advanced colorectal neoplasia.
Kim NH; Kwon MJ; Kim HY; Lee T; Jeong SH; Park DI; Choi K; Jung YS
Dig Liver Dis; 2016 Jun; 48(6):667-72. PubMed ID: 27012445
[TBL] [Abstract][Full Text] [Related]
48. Optimizing Positivity Thresholds for a Risk-Adapted Screening Strategy in Colorectal Cancer Screening.
Lu M; Wang L; Zhang Y; Liu C; Lu B; Du L; Liao X; Dong D; Wei D; Gao Y; Shi J; Ren J; Chen H; Dai M
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00398. PubMed ID: 34397041
[TBL] [Abstract][Full Text] [Related]
49. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
[TBL] [Abstract][Full Text] [Related]
50. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.
Kim NH; Lim JW; Kim S; Lim JY; Kim W; Park JH; Park DI; Sohn CI; Jung YS
Dig Liver Dis; 2019 Apr; 51(4):589-594. PubMed ID: 30733186
[TBL] [Abstract][Full Text] [Related]
51. A validated tool of combining risk factors with fecal immunochemical test for selecting colonoscopy in asymptomatic Chinese population.
Liao Y; Li S; Chen H; Chen C; Huang J; Lin F; Wang J; Yang Z
Eur J Cancer Prev; 2023 May; 32(3):275-280. PubMed ID: 32925509
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
[TBL] [Abstract][Full Text] [Related]
53. New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
Malagón M; Ramió-Pujol S; Serrano M; Amoedo J; Oliver L; Bahí A; Miquel-Cusachs JO; Ramirez M; Queralt-Moles X; Gilabert P; Saló J; Guardiola J; Piñol V; Serra-Pagès M; Castells A; Aldeguer X; Garcia-Gil LJ
PLoS One; 2020; 15(12):e0243158. PubMed ID: 33259546
[TBL] [Abstract][Full Text] [Related]
54. Colorectal cancer risk factors in asymptomatic Chilean population: a survey of international collaboration between Japan and Chile.
Okada T; Odagaki T; López-Köstner F; Zárate AJ; Ponce A; Kronberg U; Karelovic S; Flores S; Estela R; Ito T; Yasuno M; Uetake H; Kojima K; Kitagawa M
Eur J Cancer Prev; 2020 Mar; 29(2):127-133. PubMed ID: 31436751
[TBL] [Abstract][Full Text] [Related]
55. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
56. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic accuracy of risk assessment and fecal immunochemical test in colorectal cancer screening: Results from a population-based program and meta-analysis.
Wang Z; Teng J; Wu W; Dou J; Wong MCS; Gong Y; Huang J; Gu K; Xu W
Cancer Med; 2023 Sep; 12(17):18189-18200. PubMed ID: 37578430
[TBL] [Abstract][Full Text] [Related]
58. Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria.
Alatise OI; Dare AJ; Akinyemi PA; Abdulkareem FB; Olatoke SA; Knapp GC; Kingham TP;
Lancet Glob Health; 2022 Jul; 10(7):e1012-e1022. PubMed ID: 35714629
[TBL] [Abstract][Full Text] [Related]
59. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
[TBL] [Abstract][Full Text] [Related]
60. PPV and Detection Rate of mt-sDNA Testing, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchic Bayesian Meta-Analysis of the Noninvasive Colorectal Screening Tests.
Pickhardt PJ; Correale L; Hassan C
AJR Am J Roentgenol; 2021 Oct; 217(4):817-830. PubMed ID: 33703913
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
